Table 2. Pathway analyses results of DEGs (top 10 according to adjusted P value).
“Count” means how many DEGs are involved.
| ID | Description | P.adjust | Qvalue | Gene name | Count |
|---|---|---|---|---|---|
| hsa05323 | Rheumatoid arthritis | 0.000 | 0.000 | CCL20/CXCL2/CXCL3/CXCL8/HLA-DQA1/IL6/JUN/MMP1/TNFSF11/VEGFA | 10 |
| hsa04657 | IL-17 signaling pathway | 0.000 | 0.000 | CCL20/CXCL2/CXCL3/CXCL8/FOSB/IL6/JUN/MMP1/PTGS2 | 9 |
| hsa04060 | Cytokine-cytokine receptor interaction | 0.014 | 0.011 | CCL20/CX3CR1/CXCL2/CXCL3/CXCL8/IL6/TGFBR2/TNFSF11 | 8 |
| hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 0.006 | 0.005 | CXCL2/CXCL3/CXCL8/IL6/JUN/PTGS2/VEGFA | 7 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 0.003 | 0.002 | CCL20/CX3CR1/CXCL2/CXCL3/CXCL8/IL6 | 6 |
| hsa04064 | NF-kappa B signaling pathway | 0.003 | 0.002 | CXCL2/CXCL3/CXCL8/GADD45B/PTGS2/TNFSF11 | 6 |
| hsa04668 | TNF signaling pathway | 0.004 | 0.003 | CCL20/CXCL2/CXCL3/IL6/JUN/PTGS2 | 6 |
| hsa05132 | Salmonella infection | 0.006 | 0.005 | CXCL2/CXCL3/CXCL8/IL6/JUN | 5 |
| hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 0.011 | 0.008 | CXCL8/IL6/JUN/TGFBR2/VEGFA | 5 |
| hsa05134 | Legionellosis | 0.011 | 0.008 | CXCL2/CXCL3/CXCL8/IL6 | 4 |